ANTON ANDONOV

Refereed Publications

1. Andonov A, Coulthart MB, Pérez-Losada M, Crandall KA, Posada D, Padmore R, Giulivi A, Oger JJ, Peters AA, Dekaban GA. Insights into origins of Human T-cell Lymphotropic Virus Type 1 based on new strains from aboriginal people of Canada. Infect Genet Evol. 2012 Dec;12(8):1822-30.

2. H. Sachdeva, C. Green, A. Arthur, A. Andonov. Risk factors associated with a nosocomial hepatitis B outbreak in a long-term care facility in Toronto, Canada. Canadian Journal of Infection Control, 2011

3. M. Nguyen, Z.Hong, A. Dudani, A. Andonov and J. Wu. Needlestick Injuries and Bloodborne Pathogen Infections Among Health Care Workers in Canada (2000 to 2004). Fall, 2011, 320, 16-22.

2. A. Andonov. Current relevance of arbovirus infections in transfusion medicine. Vox Sanguinis, 2010; v.5, 101-106.

3. M Dawar, TL Stuart, LE Sweet, AM Neatby, LP Abbott, AP Andonov, T Wong, R Gervais, R Stirling. Canadian hepatitis C look-back investigation to detect transmission from an infected general surgeon. The Canadian Journal of Infectious Diseases and Microbiology. 2010; v.21, 6-10.

4. Berry JD, Hay K, Rini JM et al. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology. MAbs. 2010; 2(1):53-66

5. Tyler S, Andonov A, Cutts T, Cao J, Grudeski, E, Van Domselaar G, Li X and He, R. The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication. Can J Microbiol. 2009 Mar; 55(3):254-60. 6. C. Panessa, W. D. Hill, E. Giles, A. Yu, S. Harvard, G. Butt, A. Andonov, M. Krajden and C. Osiowy. Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J. Viral Hepatitis. 2009; 16, 64-73

7. Spinelli JJ, Lai AS, Krajden M, Andonov A, Gascoyne RD, Connors JM, Brooks-Wilson AR, Gallagher RP.Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada.:Int J Cancer. 2008;122(3):630-3.

8. Beniac DR, Devarennes SL, Andonov A, He R, Booth TF. Conformational Reorganization of the SARS Coronavirus Spike Following Receptor Binding: Implications for Membrane Fusion. PLoS ONE. 2007; 2(10):e1082.

9. Wu HX, Wu J., Wong T., Andonov A., Li Q., Dinner K., Donaldson T., Paton S. Enhanced Hepatitis strain surveillance system “Incidence and risk factors for newly acquired hepatitis C infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004. Eur J Clin Microbiol Infect Dis 2007 Feb 17; (Epub ahead of print)

10. Patrick D., Petric M., Skowronski, Guasparani R., Booth T., Krajden M., McGeer P., Bastien N., Gustafson L., Dubord J., MacDonald D., David S., Srour L., Parker R., Andonov A., Isaac-Renton J., Lowen N., McNabb G., McNabb A., Goh S.H., S., Astel C., Guo J.P., Drebot M., Tellier R., Plummer F., Brunham R. An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus. Can. J. Infect. Dis. Med. Microbiol. 2006; v.17, No.6, 330-336.

11. Fahim S, Prokopetz R, Jackson R, Faught C, McCarthy AE, Andonov A, Coulthart M, Daw Z, Olberg B, Giulivi A, Padmore R. Human T-cell lymphotropic virus type 1-associated adult T-cell leukemia/lymphoma in the Inuit people of Nunavut. CMAJ. 2006 Sep 12;175(6):579.

12. Beniac DR, Andonov A, Grudeski E, Booth TF. Architecture of the SARS coronavirus prefusion spike. Nature Struct Mol Biol. 2006 Aug;13(8):751-2.

13. Wu HX, Wu J, Wong T, Donaldson T, Dinner K, Andonov A, Ip Chan J, Moffat B, Baptiste B, Furseth J, Poliquin D, Bolesnikov G, Giulivi A, Paton S. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004. Scand J Infect Dis. 2006; 38(6-7):482-9. 14. Boulos D., Goedhuis N.J., Wu J., Baptiste B., Poliquin D., Furseth J., Chan J., Bolesnikov G., Barichello F., Andonov A., Giulivi A. (2005) Enhanced surveillance for acute and likely acute hepatitis B in Canada: 1999 to 2002. Canadian Journal of Infectious Diseases and Medical Microbiology, 16 (5), 275- 281.

15. Wu HX, Andonov A, Giulivi A, Goedhuis NJ, Baptiste B, Furseth J, Poliquin D, Chan JI, Bolesnikov G, Moffat B, Paton S, Wu J. (2005) Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003. Int J Med Sci.2(4), 143-6.

16. Antonishyn NA, Ast VM, McDonald RR, Chaudhary RK, Lin L, Andonov AP, Horsman GB. (2005) Rapid genotyping of hepatitis C virus by primer-specific extension analysis. J Clin Microbiol. 43(10), 5158- 63.

17. Chui,L., Drebot,M., Andonov,A., Petrich,A., Glushek,M., and Mahony,J. (2005) Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods Diagn.Microbiol.Infect.Dis. 53, 47-55.

18. Gubbins,M.J., Plummer,F.A., Yuan,X.Y., Johnstone,D., Drebot,M., Andonova,M., Andonov,A., and Berry,J.D. (2005) Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus Mol.Immunol. 42, 125-136.

19. Yap,Y., Zhang,X., Andonov,A., and He,R. (2005) Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins Comput.Biol.Chem. 29, 212-219.

20. Weingartl,H., Czub,M., Czub,S., Neufeld,J., Marszal,P., Gren,J. et al. (2004) Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. Journal of Virology. 78, 12672-12676.

21. Berry, J.D., Jones, S., Drebot, M.A., Andonov, A., Sabara, M., Yuan, X.Y., Weingartl, H., Fernando, L., Marszal, P., Gren, J., Nicolas, B., Andonova, M., Ranada, F., Gubbins, M.J., Ball, T.B., Kitching, P., Li, Y., Kabani, A. and Plummer, F. (2004) Development and characterization of neutralizing monoclonal antibody to the SARS-coronavirus (SARS-CoV). Journal of Virological Methods 120, 87-96.

22. He, R., Leeson, A., Ballantine, M.., Andonov, A., Baker, L., Dobie, F., Li, Y., Bastien, N., Feldmann, H., Strocher, U., Theriault, S., Cutts, T., Cao, J., Booth, T.F., Plummer, F.A., Tyler, S. and Li, X. (2004) Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronoavirus. Virus Research. 105(2), 121-5.

23. He, R., Andonov, A., Traykova-Andonova, M., Cao, J., Cutts, T., Grudeskie, E., Deschambault, Y., Berry, J., Drebot, M. And Li, X. (2004) Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid. Biochemical and Biophysical Research Communications. 320(4), 1199-203.

24. He, R., Dobie, F., Ballantine, M., Leeson, A., Li, Y., Bastien, N., Cutts, T., Andonov, A., Cao, J., Booth, T.F., Plummer, F.A., Tyler, S., Baker, L. and Li, X. (2004) Analysis of Multimerization of SARS-CoV nucleocapsid protein. Biochemical and Biophysical Research Communications 316(2), 476-483.

25. He, R., Leeson, A., Andonov, A., Li, Y., Bastien, N., Cao, J., Osiowy, C., Dobie, F., Cutts, T., Ballantine, M. and Li, X. (2003) Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochemical and Biophysical Research Communications 311, 870-876.

26. Krokhin, O., Li, Y., Andonov, A., Feldman, H., Flick, R., Jones, S., Stroeher, U., Bastien, N., Dasuri, K. V. N., Cheng, K., Simonsen, J. N., Perreault, H., Wilkins, J., Werner, Ens., Plummer, F. And Standing, K. G. (2003). Mass spectrometric characterization of protein from SARS virus. Molecular and Cellular Proteomics 2, 346-356.

27. Marra, M.A., Jones, S.J., Astell, C.R., Holt, R.A., Brooks-Wilson, A., Butterfield, Y.S., Khattra, J., Asano, J.K., Barber, S.A., Chan, S.Y., Cloutier, A., Coughlin, S.M., Freeman, D., Girn,N., Griffith, O.L., Leach, S.R., Mayo, M., McDonald, H., Montgomery, S.B., Pandoh, P.K., Petrescu, A.S., Robertson, A.G., Schein, J.E., Siddiqui, A., Smailus, D.E., Stott, J.M., Yang, G.S., Plummer, F., Andonov, A., Artsob, H., Bastien, N., Bernard, K., Booth, T.F., Bowness, D., Drebot, M., Fernando, L., Flick, R., Garbutt, M., Gray, M., Grolla, A., Jones, S., Feldmann, H., Meyers, A., Kabani,A., Li, Y., Normand, S., Stroher, U., Tipples, G.A., Tyler, S., Vogrig, R., Ward, D., Watson, B., Brunham, R.C., Krajden, M., Petric, M., Skowronski, D.M., Upton, C., and Roper, R.L. (2003) The Genome Sequence of the SARS-Associated Coronavirus. Science.

28. Zaman Alli, Ravinder K. Sardana, Anton Andonov, Laurian S. Robert, Johann P. Schernthaner, Béatrice Pierre, Suzanne L. Porter, Anil K. Dudani, Peter R. Ganz, Eilleen S. Tackaberry, and Illimar Altosaar. (2002) Pharming vaccines for hepatitis and cytomegalovirus: Towards the development of multivalent and subunit vaccines for oral delivery of antigens. Phytochemistry Reviews 1, 55-66.

29. Ian L. Johnson, Andonov, A., Coulthart, M . Et al. An outbreak of hepatitis B associated with reusable subdermal electroencephalogram electrodes. 2000; Canadian Medical Association Journal 162,8, 1127-1131.

30. Andonov, A., Connie Sauder, Heather Jacobsen and Rabindra Chaudhary. Comparison of six sets of PCR primers from two different genomic regions for the amplification of GB virus/hepatitis G virus.1998. J.Clin.Microbiol. v.36,286-289.

31. Andonov, A.,Teoharov, P., Bakalova, S. Predominance of Hepatitis C virus Genotype 1b in Bulgaria.1996; Europ.J.Clin.Microbiol.&Infect.Dis. v.15,521-523.

32. Chaudhary, R., Andonov, A. Hepatitis G virus a new human hepatitis virus. 1996. Canad.J.Infect.Dis. v.7.265-267.

33. Andonov, A., Chaudhary, R. Subtyping of Hepatitis C Virus Isolates with a Line Probe Assay by Hybridization.1995; J. Clin. Microbiol. 33, 1, 254-256.

34. Anodonov, A., Chaudhary, R. Genotyping of Canadian hepatitis C virus isolates by polymerase chain reaction. 1994. J.Clin. Microbiol. 32, 8:2031-2034.

35. Chaudhary, R., Andonov, A., Maclean, C. Detection of hepatitis C virus infection with RIBA-SIA and PCR.1993. J. Clin. Lab. Analysis.7, 164-167. 36. Chaudhary, R., Andonov, A. Effect of ribavirin on hepatitis A virus replication in vitro.1992. Canadian J. Infect. Dis. v.3, 67-70.

37. Teoharova, M., Draganov,P., Andonov, A., Ivanova, R. Immunological effectivity of Engerix-B vaccine in newborn children.1990. Epidemiol. Microbiol. Infect. Dis.#4, 118-123.

38. Andonov, A., Lau, P., Chaudhary, R., Nucleotide sequence of VP1 gene from a chinese strain of hepatitis A virus HAV).1989. Nucleic Acid Research, 17, #9, 30594.

39. Teoharova, M., Teoharov, P., Stankova, I., Andonov, A., Karaasheva, V., Mineva, E. DNA, RNA and protein synthesis in hepatitis A infected cells.1987. Voprosii Virusologii, #3, 304-306.

40. Mineva, E., Teoharova, M., Andonov, A. Isolation of polypeptides from purified HBsAg by gel filtration in 6M guanidine hydrochloride.1985. Problems of Infect. and Parasitic Dis.12, 30-35.

41. Teoharova, M., Teoharov, P., Andonov, A., Astrukova, S., Draganov, P. Detection of IgM antibodies against hepatitis A virus by the indirect immunofluorescent method.1985. Problems of Infect. and Parasitic Dis.12, 25-28.

42. Andonov, A,, Hristov, M., Teoharova M. Markers for hepatitis B virus infection in healthy HBsAg carriers and patients with viral hepatitis.1985. Epidemiol. Microbiol. Infect. Dis.22, #4,14-18.

43. Ognyanov, M., Andonov, A., Altunkova, I. Immunoenzyme method for detection of receptors for polymerized albumine in serum and assessment of its potential for characterization of the type of hepatitis B infection.1985. Contemporary Medicine. 36, #8, 51-55.

44. Teoharova, M., Andonov, A., Karabasheva, V., Teoharov, P., Mineva, E. Cultivation of hepatitis A virus in chronically infected systems.1985. Epidemiol. Microbiol. Infect. Dis.22, #1,7-12.

45. Teoharova, M., Andonov, A., Mineva, E., Draganov, P. Clinical and immunological studies with experimental series of hepatitis A infected cells. 1984. Voprosii Virusologii, #3, 304-306. 46. Andonov, A., Teoharova, M., Draganov, P., Astrukova, S., Ivanova, P. Viral hepatitis morbidity in Sofia district for the period of 1979-1983.1984. Epidemiol. Microbiol. Infect. Dis. 21, #4,31-38.

47. Teoharova, M., Andonov, A., Mineva, E., Draganov, P., Sharankov, N. Clinical and immunological studies on the application of experimental series of hepatitis B vaccine.1983. Problems of Infect and Parasitic Dis. 10,55-62.

48. Draganov, P., Teoharova, M., Karabasheva, V., Andonov, A., Mineva, E. On the asymptomatic transmission of hepatitis A.1983. Epidemiol. Microbiol. Infect. Dis. 20, #2,115-121.

49. Teoharova, M., Andonov, A., Mineva, E., Sharankov, N. Investigation of the immunogenic properties of a stabilized with human serum albumine hepatitis B vaccine.1982. Epidemiol. Microbiol. Infect. Dis. 19, #4,279-284.

50. Praskov, D., Ikonopisov, R., Andonov, A., Teoharova, M., Tenev, V., Tsanov, T. Influence of histon fraction f2 on the leucocyte in vitro migration in patients with melanome and skin carcinoma.1981. Problems in Oncology. #9,56-60.

51. Teoharova, M., Mineva, E., Dimitrova, Z., Karabasheva, V., Andonov, A., Losev, B., Draganov, P. Long term carriage of hepatitis A virus; detection of IgM anti-HAV in fecal samples of clinically healthy persons.1981. Epidemiol. Microbiol. Infect. Dis.18, #3,254-258.

52. Teoharova, M., Draganov, P., Andonov, A., Losev, B., Karabasheva, V., Popov, G. Long term carriage of hepatitis A virus after an outbreak of hepatitis A.1981. Epidemiol. Microbiol. Infect. Dis.18, #2,131-134.

53. Andonov, A., Teoharova, M., Losev,B., Mineva, E., Hristova, G. New diagnostic preparation for the detection of hepatitis B surface antigen.1980. Epidemiol. Microbiol. Infect. Dis.17, #4,322-326. 54. Andonov, A., Teoharova, M., Losev, B., Mineva,E., Draganov, P. Comparative studies on several methods for the detection of hepatitis B surface antigen. 1980. Epidemiol. Microbiol. Infect. Dis.17, #4,294-300.

55. Teoharova, M., Draganov, P., Astrukova, S., Andonov, A., Losev, B., Mineva, E. Serological and clinical studies on children, treated prophylactically with gammaglobuline, who later developed viral hepatitis.1980; Epidemiol. Microbiol. Infect. Dis.17, #3,202-206.

56. Mineva, E., Teoharova,M., Andonov, A., Karabasheva, V. Hepatitis B vaccine; method of development, immunogenicity, safety, reactogenicity. 1980; Epidemiol. Microbiol. I17, #2,137-144.

57. Teoharova, M., Karabasheva, V., Mineva, E., Losev, B., Andonov, A., Morphological and physical characterization of an antigen associated with viral hepatitis type A (Botevgrad antigen) 1978. Zentralblatt Bact. Hyg. I Abt. Orig. A242, 156-167.

58. Teoharova, M., Losev, B., Rashkov, K., Andonov, A., Mineva, E. Viral hepatitis non-A, non-B, in Bulgaria.1978. Epidemiol. Microbiol. Infect. Dis.15, #2,96-101.

59. Andonov, A., Draganov, P., Teoharova,M., Losev, B., Mineva, E. Dynamics of immune reactions in viral hepatitis. II. Humoral and cell-mediated immunity against HBsAg and Botevgrad antigen by the leucocyte migration inhibition test in healthy persons.1978. Epidemiol. Microbiol. Infect. Dis.15, #1,34- 41.

60. Teoharova, M., Losev, B., Andonov, A., Draganov, P., Mineva, E., Karabasheva, V. Studies on immunity in viral hepatitis type A. 1978. Voprosii virusologii, #5, 96-101.

61. Teoharova, M., Andonov, A., Draganov, P., Mineva,E., Losev, B. Dynamics of immune reactions in viral hepatitis A and B; humoral, cell-mediated immunity to HBsAg and Botevgrad antigen by leukocyte migration inhibition test in a group with high morbidity of viral hepatitis.1978. Epidemiol. Microbiol. Infect. Dis.15, #1,26-33. 62. Andonov, A. Subtyping of hepatitis B surface antigen in Bulgarian isolates.1977. Epidemiol. Microbiol. Infect. Dis.14, #4,295-298.

63. Teoharova, M., Losev,B., Andonov, A., Draganov, P., Mineva,E., Karabasheva, V. Viral hepatitis A and Botevgrad antigen.1977. Epidemiol. Microbiol. Infect. Dis.14, #4,285-295.

64. Andonov, A., Prihodkov, V., Teoharova, M. Dynamics of humoral and cell-mediated immunity for hepatitis A and B in a healthy closed military unit.1977. Military Medicine. 31, #6,36-40.

65. Teoharova, M., Andonov, A., Astrukova, S., Losev, B., Mineva, E., Draganov, P. Development of antibodies to the hepatitis B surface antigen and Botevgrad antigen in patients with viral hepatitis.1977; Epidemiol. Microbiol. Infect. Dis.14, #2,107-113.

66. Teoharova, M., Mineva, E., Karabasheva, V., Losev,B., Andonov, A., Draganov, P. Purification and characterization of an antigen associated with viral hepatitis type A (Botevgrad antigen). 1977. Epidemiol. Microbiol. Infect Dis.14, #1, 29-33.

67. Andonov, A., Teoharova, M., Astrukova, S., Losev, B., Mineva, E., Draganov, P. Development of cell-mediated immunity in patients with viral hepatitis. 1976. Voprosii Virusologii, #3, 331-337.

68. Teoharova, M., Losev, B., Andonov, A., Bradvarova, I. Cultivation of some enteroviruses in nonpermissive cell culture of human lung embrio in the presence of 5'Brom deoxyuridine.1976. Epidemiol. Microbiol. Infect. Dis.v. 13, #4,297-301.

69. Losev, B., Andonov, A., Teoharova, M., Astrukova, S. Prophylactic and clinical studies; interferogenic response during the development of cell-mediated immunity to hepatitis B and Botevgrad antigen in patients with acute viral hepatitis.1976. Contemporary Medicine, v.27,9-13.

70. Teoharova, M., Donchev, M.,Donchev,T., Astrukova, S., Draganov,P., Andonov, A., Losev, B. Hepatitis B antigen and antibodies in liver disease.1976. Internal Diseases #3, 107-108. 71. Teoharova, M., Mineva, E., Losev,B., Andonov, A., Rashkov, R. Preparation of goat antiserum to hepatitis B antigen.1975. Acta Medica Bulgarica, #2,31-36.

72. Andonov, A. Delayed type of hypersensitivity against the hepatitis B surface antigen in guinea pigs.1975; Epidemiol. Microbiol. Infect. Dis.v. 12, #4,305-311.

73. Losev, B., Baleva, M., Andonov, A. Detection of hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) in liver biopsies and serum samples.1975. Epidemiol. Microbiol. Infect. Dis.v. 12, #3,197-201.

74. Teoharova, M., Draganov, P., Andonov, A., Losev, B., Mineva, E. Serologic studies on viral hepatitis B in endemic regions during an outbreak of viral hepatitis B.1974. Epidemiol. Microbiol. Infect. Dis. v.11,#4,350-355.

75. Draganov, P., Andonov, A., Losev, B. Karagyosov, A. Epidemiologic and serologic studies on hemotransfused patients with viral hepatitis.1974. Epidemiol. Microbiol. Infect. Dis.v. 11, #3,85-88.

76. Andonov,A., Teoharova, M., Mineva, E. Development of passive hemagglutination test for detection of antibody to the hepatitis B surface antigen.1974. Epidemiol. Microbiol. Infect. Dis.v. 11, 176-182.

77. Andonov, A. On some characteristics of the passive hemagglutination test.1974. Epidemiol. Microbiol. Infect. Dis. v.11, 207-209.

78. Andonov, A. Variation of antigenic and biological properties of influenza virus A2 after continuous passages in egg embrios in the presence of homologus immune antiserum. 1972. Epidemiol. Microbiol. Infect. Dis.v. 9, #4,319-324.

Book Chapters

Andonov, A. Immune response in hepatitis B infection. in Problems Viral hepatitis,1975; Sofia, 18-33.

Teoharova, M., Andonov, A., Losev, B., Mineva, E., Draganov, P. Viral hepatitis in People's Republic of Bulgaria in Uspehi hepatologii (Success of Hepatology),1982; Riga, 188-201.

Invited presentations:

Arbovirus infections in transfusion medicine". XII International Symposium Hematology and V Immunohematology Journey Instituto Sírio-Libanês de Ensino e Pesquisa, Hospital Sírio-Libanês,Sao Paulo, Brazil, May 20-22, 2010.

Ecology of arboviral vector-borne diseases. XII International Symposium Hematology and Sírio- Libanês V Immunohematology Journey Instituto Sírio-Libanês de Ensino e Pesquisa, Hospital,Sao Paulo, Brazil, May 20-22, 2010.

Current relevance of Arbovirus infections in transfusion medicine. Plenary lecture, XXXI Congress of the International Society for Blood Transfusion, Berlin, June, 2010

SARS-coronavirus interaction with ACE-2 receptor; implications for virus adaptation and vaccine design. 2006, 11th Congress of the Bulgarian microbiologists, Varna, Bulgaria.

Food and Drug Administration, Blood Products Advisory Committee, 76th Meeting,

June19-20, 2003. Gaithersburg, MD, US. “SARS: Canadian studies (epidemiology and virology), implications for blood safety”.

VIII European Congress of the International Society of Blood Transfusion, July 5-9, 2003, Istanbul, Turkey. State of the art lecture; “The virological aspects of SARS Coronavirus”. Novel mechanisms for vaccines through food; Edible vaccines: 2002, Business of science symposium, Winnipeg, Manitoba.

Molecular Diagnostics of Viral Hepatitis Infections. First Balkan Conference of Microbiology, Plovdiv, Bulgaria, October 5-9, 1999.

Plant-based viral vaccines. Plant biotechnology symposium: October 9th,1997, Plovdiv, Bulgaria.

Guest speaker at the Ortho Diagnostic/Canadian Red Cross Scientific Meeting (Ottawa, 1994). Genotyping of Canadian HCV Isolates by PCR.

Conference Proceedings:

a) Oral presentations

Incidence and risk factors for Newly Acquired (Acute) Hepatitis C Virus Infection among Aboriginal versus non-Aboriginal Canadians in Eight Health Regions, Canada, 2004-2009; 7th World Alliance for Risk Factor Surveillance (WARFS) Global Conference in Toronto, October 16-19, 2011.

SCREENING FOR X/P-MLV RELATED VIRUS SEQUENCES IN CANADIAN PATIENTS WITH MULTIPLE BLOOD TRANSFUSIONS. 21st Regional Congress of ISBT, Europe, Lisbon, June 18-22, 2011.

Chronic Hepatitis E in a Canadian HIV patient; AMMI-CACMID, Montreal, 2011

Hepatitis E Virus Infection (HEV) in Canada; when can we depend upon serology alone for diagnosis. AMMI-CACMID, Edmonton, May 2010

Laboratory testing for viral hepatitis in Canada. AMMI-CACMID, Edmonton, May 2010 Arbovirus infections in transfusion medicine. XII International Symposium Hematology and V Immunohematology Journey Instituto Sírio-Libanês de Ensino e Pesquisa, Hospital Sírio-Libanês,Sao Paulo, Brazil, May 20-22, 2010.

2. Immunohematology Journey Instituto Sírio-Libanês de Ensino e Pesquisa, Hospital Ecology of arboviral vector-borne diseases. XII International Symposium Hematology and Sírio-Libanês,Sao Paulo, Brazil, May 20-22, 2010.

3. Current relevance of Arbovirus infections in transfusion medicine. Plenary lecture, XXXI Congress of the International Society for Blood Transfusion, Berlin, June, 2010

A Follow up Study on Canadian Blood Donors Testing Positive for Hepatitis B anti-core Antibody M. Fearon*, V. Scalia, S. O’Brien, Q. Yi, G. Xi, W. Fan, I. Dines, M. Huang, S. Kleinman, A. Andonov Canadian Society for Transfusion Medicine, June 4-7, 2009, Ottawa

Solvent detergent-treated plasma: risk of transfusion-transmitted non-enveloped viruses. A.Andonov, G. Rock, M. Morbey, K. Swidinsky, L.Lin. E. Grudeski, J. Wu and the Canadiana Apheresis Group. Canadian Apheresis Society Meeting, May, 2008, Ottawa.

Hepatitis D Virus Infection in Canada: Current Prevalence and HDV Genotypes: K. Swidinsky, M. Morbey, E. Grudeski, K. Kaita, A. Andonov. CACMID, Vancouver, 2008

D.R. Beniac, S.L. deVarennes, A. Andonov, T.F. Booth. Negative Staining and cryo-3DEM of Viral Structures. 35th Annual Meeting of the Microscopical Society of Canada, Montreal, Quebec, Canada, 20- 23 May 2008.

Anton Andonov, Lisa Lin, Carla Osiowy, Elsie Grudeski and Amanda Cameron. A retrospective study on occult Hepatitis B Virus (HBV) infection in Indochinese immigrants to Canada; phylogenetic analysis of the s-gene. XVIIIth Regional Congress of the International Society of Blood Transfusion, Hanoi, Vietnam, November 10-13, 2007. D.R. Beniac, S.L. deVarennes, A. Andonov, T.F. Booth. Cryo-electron microscopy and three- dimensional reconstruction of the SARS coronavirus. June 12-15, 2007. 34th Annual Meeting of the Microscopical Society of Canada, Edmonton, Alberta, Canada.

A. Andonov, S. Samson, M. Drebot, J. Berry, M. Gubbins, M. Andonova, E. Grudeski, S. Tyler. Molecular characterization of monoclonal antibodies against the spike (S) protein of SARS coronavirus (SARS-CoV): 2006, Canada-CACMID, Victoria, BC.

Hong-Xing Wu, Jun Wu, Tom Wong, Anton Andonov, Qiong Li, Tracey Donaldson, Katherine Dinner, Jennifer Siushansian, Shirley Paton & all EHSSS sentinel sites. Incidence of recent hepatitis C infection in Aboriginal versus Non-Aboriginal Canadaian Females, 1999-2004. 2006. International Conference on Women and Infectious Diseases, Atlanta, US.

E. Grudeski, A.Andonov, J. Berry, M.traykova-Andonova, M. Drebot. Maximizing Sensitivity of SARS Coronavirus Detection by Antigen-Capture Real Time PCR. 2004. 72nd CACMID, Regina, Saskatchewan.

A.Andonov, E. Grudeski, M.Morbey. Molecular epidemiology of Hepatitis a Virus (HAV) in Canada. 2004. 72nd CACMID, Regina, Saskatchewan.

Agnes SW Lai, John J Spinelli, Randy D Gascoyne, Joseph M Connors, Anton Andonov, Mel Krajden, Darrel Cook, Pat Lee, Rozmin Janoo-Gilani; The prevalence of hepatitis C virus infection in patients of non-Hodgkin’s lymphoma in British Columbia: A case-control study.October 14-17, 2004. Third Annual American Association of Cancer Research Conference.

Lin, L., Traykova-Andonova, M., Drebot, M., Gallad, M., Andonov, A. Quantitative TaqMan RT- PCR Test for SARS Coronavirus (SARS-CoV). 2003. 71st Annual CACMID (Canadian Association for Clinical Microbiology and Infectious Diseases) Meeting, Montreal, Quebec.

A. Andonov, M.Morbey, J. Rochefort. Performance characteristics of INNO-LIA HCV III Update assay for confirmation of HCV antibodies. 2003. CACMID, Montreal, Quebec. L.Lin, K.Nicholson and A. Andonov: Hepatitis C Virus Genotyping; Pitfalls and potential. 2001, AMMI Canada-CACMID, Victoria, BC.

Fearon, M.., Johnson, I., Nicholas, K., Chaudhary, R., Andonov, A. Tyler, S., Hockin, J. An outbreak of hepatitis B associated with EEG clinics in Toronto. 1997. 65th CACMID Meeting, St. John’s, Newfoundland.

Andonov, A., Jacobsen, H. Enhanced sensitivity of an immunoblot assay for the detection of anti-HCV core antibody. 1995. 63rd CACMID Meeting, Winnipeg, Manitoba.

Mineva, E., Andonov, A., Teoharova, M. Investigation of antigenic and immunogenic properties of temperature and formaline killed hepatitis B vaccines. 1978. VII International Congress of Infectious Diseases, Varna, 36-39.

Andonov, A., Teoharova, M., Losev, B., Mineva, E., Draganov, P., Astrukova, A., Krastev, K. Cell- mediated and humoral immune response to hepatitis type A and B viruses.1978. VII International Congress of Infectious Diseases, Varna, 40-43.

Gabev, E., Minev, M., Andonov, A., Dimitrova, T. Acute viral hepatitis and HLA.1978. VII International Congress of Infectious Diseases, Varna, 49-51.

Teoharova, M., Draganov, P., Losev, B., Andonov, A., Mineva, E., Astrukova, A., Karabasheva, V. Etiology and Epidemiology of viral hepatitis in Bulgaria.1974.

VI International Congress of Infectious Diseases, Warszawa, v. II, 109-113.

b) Posters (last three years) Preliminary estimates of chronic hepatitis B infection in Canada.Hong-Xing Wu, Anil Dudani, Qiong Li, Anton Andonov, Jun Wu. 8th Canadian Immunization Conference in Toronto, November 30 to December 3, 2008.

Anton Andonov, Gail Rock, Michael Morbey, Ken Swidinsky, Lisa Lin, Elsie Grudeski, Jun Wu and the Canadian Apheresis Group (CAG). Solvent detergent-treated plasma: risk of transfusion-transmitted non-enveloped viruses. XVIIIth Regional Congress of the International Society of Blood Transfusion, Hanoi, Vietnam, November 10-13, 2007.

Anton Andonov, Shaun Tyler, Mike Drebot, Elsie Grudeski, Maya Traykova-Andonova, Jody Berry, Runtao He and Todd Cutts. Molecular evolution of SARS coronavirus (SARS-CoV) in vitro: putative open reading frames (ORFs) 9, 10, 11 are not essential for virus replication. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum, 2006,Winnipeg, MB.

M. Andonova, R. He, J. Berry, X.Li, A. Andonov, M. Drebot. Antiviral effect of aurintricarboxilix acid (ATA) on West Nole virus and SARS coronavirus (SARS-CoV) infection: different mechanisms of action? 2006, AMMI Canada-CACMID, Victoria, BC.

A. Andonov, L. Lin, G. Wong, D. Boulos, A. Tweed, F. Barichello, M. Krajden, T. Booth. Identification of newly acquired hepatitis C virus (HCV) infection in British Columbia based on recent serocnversion: genotype distribution for 2003-2004. 2004, 2nd Canadian conference on hepatitis C, Vancover, BC.